Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Infectious Diseases|October 28, 2020
Bibliometric Analysis of Early COVID-19 Research: The Top 50 Cited PapersHassan ElHawary, Ali Salimi, Nermin Diab, et al.Frontiers in Public Health|July 29, 2020
The North American Layman's Understanding of COVID-19: Are We Doing Enough?Ali Salimi, Hassan ElHawary, Nermin Diab, et al.Lung|October 13, 2022
Narrative Review of the Mechanisms and Treatment of Cough in Asthma, Cough Variant Asthma, and Non-asthmatic Eosinophilic BronchitisNermin Diab, Matthew Patel, Paul O'Byrne, et al.Expert Opinion on Emerging Drugs|April 15, 2023
Emerging drugs in the treatment of chronic coughDanica Brister, Mustafaa Wahab, Moaaz Rashad, et al.Plos One|August 8, 2023
The added value of haemoglobin to height, age, and sex to predict DLCO in subjects with preserved exercise capacityEldar Priel, Nermin Diab, Matthew Patel, et al.American Journal of Respiratory and Critical Care Medicine|July 7, 2018
Underdiagnosis and Overdiagnosis of Chronic Obstructive Pulmonary DiseaseNermin Diab, Andrea S Gershon, Don D Sin, et al.Lung|September 13, 2024
The Effects of Diabetes on Gas Transfer Capacity, Lung Volumes, Muscle Strength, and Cardio-pulmonary Responses During ExerciseEldar Priel, Emir Ali, Danica Brister, et al.Current Medicinal Chemistry|February 10, 2018
New Drugs, Therapeutic Strategies, and Future Direction for the Treatment of Pulmonary Arterial HypertensionValentina Mercurio, Anna Bianco, Giacomo Campi, et al.Scientific Reports|September 13, 2019
Prevalence and Risk Factors of Thyroid Dysfunction in Older Adults in the CommunityNermin Diab, Natalie R Daya, Stephen P Juraschek, et al.JAMA|September 11, 2023
Efficacy and Tolerability of Gefapixant for Treatment of Refractory or Unexplained Chronic Cough: A Systematic Review and Dose-Response Meta-AnalysisElena Kum, Matthew Patel, Nermin Diab, et al.Pageof 2